Loading data
DOCNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 603.99 m USD | 568.48 m USD | 527.42 m USD | 494.94 m USD | 471.33 m USD |
| Cost of revenue | — | 1.07 bn USD | 902.06 m USD | 862.99 m USD | 773.28 m USD |
| Interest expense | 305.18 m USD | 280.43 m USD | 200.33 m USD | 172.94 m USD | 157.98 m USD |
| Income tax expense | 9.28 m USD | 4.35 m USD | -9.62 m USD | -4.43 m USD | -3.26 m USD |
| Net income (reported basis) | 101.03 m USD | 267.3 m USD | 334.76 m USD | 516.42 m USD | 525.93 m USD |
| Net income attributable to common shareholders | 70.51 m USD | 242.38 m USD | 304.28 m USD | 497.79 m USD | 502.27 m USD |
| Basic earnings per share | 0.1 USD/share | 0.36 USD/share | 0.56 USD/share | 0.92 USD/share | 0.93 USD/share |
| Diluted earnings per share | 0.1 USD/share | 0.36 USD/share | 0.56 USD/share | 0.92 USD/share | 0.93 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.